Veterinary Infectious Disease Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Veterinary Infectious Disease Therapeutics Market is Segmented by Product Type (Antibiotics, Antiviral, Antifungal, Amebicides, and Others), Animal Type and Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Microorganisms are tiny living creatures that are present everywhere, such as bacteria and viruses. Few of the thousands of species of microorganisms invade, multiply, and cause illness in animals and people. Most of the microorganisms live on the skin, in the mouth, upper airways and intestines without causing any harmful disease but some of the microorganism lives in or on a pet, or invades and causes disease depends on the nature of the microorganism and the state of the pet’s natural defenses. 

According to World Small Animal Veterinary Association (WSAVA), estimates that 60% to 80% of emerging diseases are zoonotic which indicates the importance of veterinarians in the identification, prevention, and control of infectious diseases. For Example, Rift Valley Fever is an endemic zoonotic disease in Africa and the Middle East that costs producers USD 427 million every year. Increasing prevalence of infectious disease and increasing demand for dairy, meat, and poultry products due to the increasing population size are the key driving factors in the veterinary infectious disease therapeutics market.

Scope of the Report

As per the scope of the report, veterinary infectious diseases are the diseases that can get transmitted from one animal to another animal or into a human being. Despite their overwhelming abundance, relatively few of the hundreds of thousands of species of microorganisms invade, multiply, and cause illness in animals and people.

By Product Type
By Animal Type
Dogs and Cats
Other Animals
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Antibiotics Segment is Expected to Hold a Major Market Share in the Veterinary Infectious Disease Therapeutics Market

Antibiotic drugs are generally used in veterinary medicine to treat infectious diseases that are caused by bacteria and other microorganisms. Different classes of antibiotics are available for the treatment of infectious diseases in animals, including penicillins, cephalosporins, cephamycins, aminoglycosides, etc. Zoonotic diseases are infectious diseases caused by infections, organisms, and parasites that spread between animals and humans. According to the Centers for Disease Control and Prevention, in the year 2017, found that 24,484 foodborne illnesses, 5,677 hospitalizations, and 122 deaths are caused due to zoonotic diseases.

Hence, owing to the rising number of zoonotic diseases, along with rising pet ownership and increasing research and development (R&D) activities in the veterinary therapeutics are expected to drive the market growth.

Pet Ownership.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a major market share in the global veterinary infectious disease therapeutics market due to the rising prevalence of veterinary infectious disease, rising companion animal healthcare expenditure in this region. As per the American Heartworm Society, the number of dogs diagnosed with heartworm per clinic has risen by 21 percent in the United States and its territories between 2013 and 2016. Moreover, increasing the adoption of veterinary products and advancements in veterinary infectious disease therapeutics technology is fueling the growth of the overall regional market to a large extent.

 Veterinary Infectious Disease Therapeutics Market 2

Competitive Landscape

The veterinary infectious disease therapeutics market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the major market players are Elanco, Merck & Co. Inc, Boehringer Ingelheim Vetmedica, Zoetis, Dechra Pharmaceuticals PLC, Ceva Sante, Virbac S.A, Bayer AG, Vetoquinol S.A, IDEXX Laboratories, Inc.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Infectious Diseases in Animals

      2. 4.2.2 Technological Advancements in Development of New Drugs

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Government Regulations

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 Antibiotics

      2. 5.1.2 Antiviral

      3. 5.1.3 Antifungal

      4. 5.1.4 Amebicides

      5. 5.1.5 Others

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Swine

      4. 5.2.4 Poultry

      5. 5.2.5 Other Animals

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Elanco

      2. 6.1.2 Merck & Co. Inc

      3. 6.1.3 Boehringer Ingelheim Vetmedica, Inc.

      4. 6.1.4 Zoetis Inc.

      5. 6.1.5 Dechra Pharmaceuticals PLC

      6. 6.1.6 Ceva Santé Animale

      7. 6.1.7 Virbac S.A

      8. 6.1.8 Bayer AG

      9. 6.1.9 Vetoquinol S.A

      10. 6.1.10 IDEXX Laboratories, Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Veterinary Infectious Disease Therapeutics Market market is studied from 2018 - 2026.

The Veterinary Infectious Disease Therapeutics Market is growing at a CAGR of 5.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Elanco, Merck & Co. Inc, Boehringer Ingelheim Vetmedica, Zoetis, Dechra Pharmaceuticals PLC are the major companies operating in Veterinary Infectious Disease Therapeutics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!